Filing Details
- Accession Number:
- 0001437749-15-011816
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-04 16:47:48
- Reporting Period:
- 2015-06-02
- Filing Date:
- 2015-06-04
- Accepted Time:
- 2015-06-04 16:47:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1498021 | Examworks Group Inc. | EXAM | Services-Health Services (8000) | 272909425 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1501276 | Clare Arguedas | 1820 Ringling Blvd Sarasota FL 34236 | Gc, Evp And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-02 | 10,000 | $9.47 | 37,566 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-02 | 10,000 | $40.40 | 27,566 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-02 | 2,133 | $38.94 | 25,433 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-02 | 776 | $40.03 | 24,657 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-02 | 2,911 | $40.27 | 21,746 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-06-02 | 10,000 | $0.00 | 10,000 | $9.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,667 | 2022-01-04 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.25 to $40.59, inclusive. The Reporting Person undertakes to provide ExamWorks Group, Inc., any security holder of ExamWorks Group, Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- Sales pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (purpose includes sales to cover tax obligations due upon vesting of restricted shares).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.75, inclusive. The Reporting Person undertakes to provide ExamWorks Group, Inc., any security holder of ExamWorks Group, Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.76 to $40.41, inclusive. The Reporting Person undertakes to provide ExamWorks Group, Inc., any security holder of ExamWorks Group, Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.13 to $40.41, inclusive. The Reporting Person undertakes to provide ExamWorks Group, Inc., any security holder of ExamWorks Group, Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- On January 4, 2012, the reporting person was granted an option to purchase 40,000 shares of common stock. The option vested in three equal annual installments beginning on January 4, 2013.